REYON Pharmaceutical Co., Ltd.

KRX:102460.KS

13350 (KRW) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income 3,583.3737,433.6825,537.2523,844.4275,939.8021,341.49212,886.90110,701.36911,337.93311,593.28611,292.96116,990.55919,779.37419,981.93316,287.9938,065.5476,086.421
Depreciation & Amortization 4,782.2344,533.514,665.7034,564.6424,088.3071,866.9512,005.0691,942.1851,759.691,854.7872,396.6962,341.2782,156.9322,233.2252,547.5452,499.1413,299.908
Deferred Income Tax 00000-28,664.221-277.3520-568.43500000000
Stock Based Compensation 00000000000000000
Change In Working Capital -3,362.466-290.3581,781.89-1,271.1192,621.297,584.3163,214.565-365.8836,529.4864,402.259-9,022.797,177.02-3,029.304-5,398.212-11,075.969-6,729.974-2,870.169
Accounts Receivables 1,893.018-924.923200.6864,274.1455,232.1344,930.9783,090.136-1,051.697-818.61500000000
Inventory -5,067.153-3,677.2362,005.489-4,431.26-3,208.26890.614-686.152895.584-2,552.5513,638.926-5,532.3470178.899-2,778.583-3,784.676-4,767.7-1,632.166
Accounts Payables 3,393.92761.523563.60949.389433.699217.839530.355-494.492488.76600000000
Other Working Capital -3,582.2584,250.278-987.894-1,163.393163.7176,693.7023,900.717-1,261.4679,082.037763.333-3,490.4430-3,208.203-2,619.629-7,291.293-1,962.274-1,238.003
Other Non Cash Items 2,130.204-2,947.66-300.316-2,538.544-24,832.915656.451-1,342.57-2,806.233-9,963.208-2,747.888-4,718.66-4,438.811-5,668.3611,374.499923.972,151.0281,532.866
Operating Cash Flow 7,133.3458,729.17411,684.5284,599.407-12,183.51611,449.2116,763.9659,471.4389,663.90115,102.444-51.79322,070.04613,238.64118,191.4458,683.5395,985.7428,049.026
Investing Activities:
Investments In Property Plant And Equipment -28,872.449-63,133.217-116,996.723-52,312.679-51,380.443-39,416.459-4,687.636-3,213.551-4,840.174-5,755.877-4,351.144-14,131.481-4,279.845-4,852.37-3,315.718-2,863.386-4,762.395
Acquisitions Net 1.72142.273-10.7425.833-4,809.963-2,592.08-41.656-792.77-3,763.728-3,340.40900-167.5-2,329.453-1,856.033-797.821-691.108
Purchases Of Investments -10,034.751-65,860-85,324.403-2,240-420.06-78,710.455-48,013.2-7,027.197-540-4,486.8-5,472.92-8,799.364-4,667.131-30,185.059-10,370.515-7,848.416-11,054.402
Sales Maturities Of Investments 30,013.97176,425.7887,40024,462.1489,406.372128,659.3561,840.5033,505.2899,216.8422,738.15300452.2358,8508,427.685,894.51,972.027
Other Investing Activites 152.119-38.927249.870.4101.984-289.23853.934815.1893,781.7093,513.48120.7544.545-209.4972,510.2671,882.69786.18641.147
Investing Cash Flow -8,739.39-52,564.092-114,682.026-29,594.30732,897.8917,651.124-50,848.055-6,713.0413,854.649-7,331.452-9,803.31-22,926.3-8,871.738-26,006.615-5,231.896-4,828.943-13,894.731
Financing Activities:
Debt Repayment -13,100-113,900-151,125.418-30,222.289-26,049.920-2,0000-12,811.765-5,946.2980-429.705-4,992.681-5,377.328-4,871.13-6,589.333-4,894.317
Common Stock Issued -3.83010,000-45.2740039,777.70100000010,447.85903608,072.878
Common Stock Repurchased 00-76.30800-4,975.645-26.7920000000004,000
Dividends Paid -2,737.914-4,563.189-3,464.053-5,784.756-8,263.938-5,869.05-4,515-3,870-3,2250000-1,101.48-615.06-594-675
Other Financing Activities -3.83111,695.723302,241.6076,954.72610,645.7590-172.5150007,724.2461,973.50103,0003,0005,840-100
Financing Cash Flow 8,153.339-6,767.466157,575.82831,392.259-23,668.098-10,844.69633,063.394-3,870-12,811.765-5,946.2987,724.2461,543.796-4,992.6816,969.051-2,486.19-983.3336,403.561
Other Information:
Effect Of Forex Changes On Cash -1.283-89.039-33.998-26.172-0.385-6.4-0.234-01.304-00000000
Net Change In Cash 8,057.794-50,691.42354,544.3326,371.186-2,954.1078,249.238-1,020.931-1,111.603708.0881,824.693-2,130.857687.543-625.779-846.119965.453173.466557.856
Cash At End Of Period 24,106.98116,049.18766,740.6112,196.2785,825.0928,779.199529.9611,550.8932,662.4961,954.408129.7142,260.5711,616.4142,243.1533,089.2722,123.8191,950.353